• Biotinylated Human GPA33 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
  • The purity of Biotinylated Human GPA33 is greater than 95% as determined by SEC-HPLC.
  • Immobilized Anti-GPA33 Antibody, hFc Tag at 0. 5 Mu g/ml (100 Mu l/well) on the plate. Dose response curve for Biotinylated Human GPA33, His Tag with the EC50 of 11. 0ng/ml determined by ELISA.

Human GPA33/A33 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001770)

SKU:
STJP001770

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human GPA33/A33-C-His-Avi protein was developed from hek293 and has a target region of C-His-Avi. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Gene Symbol: GPA33
Gene ID: 10223
Uniprot ID: GPA33_HUMAN
Immunogen Region: Ile22-Val235
Immunogen: DNA sequence encoding Human GPA33/A33 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
Post Translational Modifications N-glycosylated, contains approximately 8 kDa of N-linked carbohydrate. Palmitoylated.
Function May play a role in cell-cell recognition and signaling.
Protein Name Cell Surface A33 Antigen
Glycoprotein A33
Cellular Localisation Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names Cell Surface A33 Antigen protein
Glycoprotein A33 protein
GPA33 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance